Treatment of adult T‐cell leukemia/lymphoma: past, present, and future
- 10 December 2007
- journal article
- review article
- Published by Wiley in European Journal of Haematology
- Vol. 80 (3), 185-196
- https://doi.org/10.1111/j.1600-0609.2007.01016.x
Abstract
Adult T-cell leukemia/lymphoma (ATLL) is a peripheral T-cell malignancy caused by human T-cell lymphotrophic virus type I. Clinical manifestations of ATLL range from smoldering to chronic, lymphoma and acute. Patients with acute and lymphoma type ATLL require therapeutic intervention. Conventional chemotherapeutic regimens used against other malignant lymphoma have been administered to ATLL patients, but the therapeutic outcomes of acute and lymphoma type ATLL remain very poor. Promising results of allogeneic stem cell transplantation (SCT) for ATLL patients have recently been reported and the treatment outcome might be improved for some ATLL patients. Besides conventional chemotherapy and SCT, interferon, zidovudine, arsenic trioxide, targeted therapy against surface molecule on ATLL cells, retinoid derivatives, and bortezomib have been administered to ATLL patients in pilot or phase I/II studies. Further studies are required to confirm the clinical benefits of these novel therapeutics. This article reviews the current status and future directions of ATLL treatment.Keywords
This publication has 127 references indexed in Scilit:
- Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibodyLeukemia, 2007
- Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cellsBritish Journal of Cancer, 2007
- Human T-Cell Leukemia Virus Type 1 Tax Dysregulates β-CateninSignalingJournal of Virology, 2006
- Emodin and DHA potently increase arsenic trioxide interferon-α–induced cell death of HTLV-I–transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1Blood, 2006
- Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescenceBlood, 2006
- Cyclic Induction of Senescence with Intermittent AZT Treatment Accelerates both Apoptosis and Telomere LossBreast Cancer Research and Treatment, 2005
- Hypercalcemia Associated with CancerThe New England Journal of Medicine, 2005
- Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitroLeukemia, 2004
- Expression of parathyroid hormone-related protein in a human T cell lymphotrophic virus type I-infected T cell lineBiochemical and Biophysical Research Communications, 1988
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProceedings of the National Academy of Sciences of the United States of America, 1980